Progress
Target Validation Completed
What is this?
Lead Optimisation Completed
What is this?
Candidate Selection Completed
What is this?
Proof of concept Completed
What is this?
PK Study Completed
The pharmacokinetics study will provide the validation that the peptide is delivered to the spinal cord after injection.
PD Study In-Progress
The pharmacodynamic study will provide the validation that the peptide successfully reduces CSPGs after injection.
Dosage Study Dependent on earlier study results
The dosage study will enable us to work out the correct doseage and length of treatment.
Toxicology Dependent on earlier study results
Toxicology needs to be performed to make sure the peptide is safe for use.
Regulatory Approval In-Progress
Regulatory approval is needed to start a clinical trial. We are working with regulatory agencies to provide all required information.
This process is being run in parallel with obtaining all the information required from the ongoing studies.
Clinical Trials Start Date Dependent on earlier study results
If everything is success and we achieve regulatory approval we plan to initiate clinical trials as soon as possible.
Register for updates
